Managers / Q4 2022 · view latest →
AMJ Financial Wealth Management
CIK 0001801585 · 44160 SCHOLAR PLAZA, SUITE 490, LEESBURG, VA, 20176 · 7034660477
Summary
Amj Financial Wealth Management reported $169M in U.S.-listed holdings across 55 positions for Q4 2022.
Its largest position, Pgim Ultra Short Bond Etf, represents 9.9% of the portfolio.
Compared with Q3 2022, the fund opened 13 new positions and exited 7.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 61.4% · $104M
- ETP · 37.8% · $64M
- Other · 0.6% · $952,520
- REIT · 0.2% · $407,506
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SLVISHARES SILVER TRUST | NEW | +393.4K | 393.4K | +$9M | $9M |
| SPDR GOLD MINISHARES TRUST | NEW | +230.7K | 230.7K | +$8M | $8M |
| GDGENERAL DYNAMICS CORP COM | NEW | +18.8K | 18.8K | +$5M | $5M |
| TXTTEXTRON INC COM | NEW | +33.6K | 33.6K | +$2M | $2M |
| GUGGENHEIM ETF TRUST S&P 500 EQUAL WEIGHT | NEW | +15.0K | 15.0K | +$2M | $2M |
| HCAHCA HEALTHCARE INC COM | NEW | +6.6K | 6.6K | +$2M | $2M |
| VRTXVERTEX PHARMACEUTICALS INC COM | NEW | +5.1K | 5.1K | +$1M | $1M |
| ISHARES FLOATING RATE BOND ETF | NEW | +11.6K | 11.6K | +$581,437 | $581,437 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $424M | 86 | May 8, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $423M | 90 | Feb 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $420M | 90 | Nov 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $402M | 85 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $339M | 85 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $362M | 84 | Feb 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $349M | 84 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $323M | 74 | Aug 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $299M | 77 | May 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $238M | 69 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $217M | 65 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $228M | 71 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $155M | 57 | May 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $169M | 55 | Feb 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $154M | 49 | Nov 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $118M | 54 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $250M | 84 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $277M | 93 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $244M | 90 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $230M | 89 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $207M | 83 | May 7, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $196M | 74 | Feb 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $170M | 64 | Oct 23, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $147M | 63 | Aug 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $58M | 29 | May 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $142M | 69 | Feb 10, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.